Rosomni-Gold 75/75/20 by EMK Omni Pharma is a prescription-only cardiovascular care capsule that combines a higher-strength statin with two antiplatelet agents. Each hard gelatin capsule contains Aspirin IP 75 mg as enteric-coated pellets, Rosuvastatin Calcium IP equivalent to Rosuvastatin 20 mg and Clopidogrel Bisulphate IP equivalent to Clopidogrel 75 mg, both in immediate-release form. Rosuvastatin lowers LDL cholesterol and stabilises arterial plaque, while Aspirin and Clopidogrel reduce the tendency of platelets to form clots.
Rosomni-Gold 75/75/20 may be prescribed by cardiologists and physicians for patients who require combined antiplatelet therapy and intensive cholesterol lowering as part of doctor-supervised secondary prevention after a heart attack, stent placement or other cardiovascular event, where the 20 mg rosuvastatin strength is preferred over the 10 mg Rosomni-Gold 75/75/10 combination. It is intended strictly for physician-guided treatment. Patients should swallow the capsule whole, should not self-medicate or stop the medicine without consulting their doctor, and should report any unusual bleeding.